GlassScriptPhysician profile
Angela Hamilton
NPI 1215470489
$5,039.05
in general payments reported to CMS, 2019-2025
39 companies · $1,235 in 2025
The $1,235 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $959 · 2023: $1,437 · 2024: $1,084 · 2025: $1,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,754.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,274.50 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $687.05 | 2022-2025 | Xifaxan, Trulance, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $442.34 | 2022-2025 | Entyvio, Eohilia |
| Genzyme Corporation | $396.33 | 2022-2025 | |
| Janssen Biotech, INC. | $388.27 | 2021-2025 | Stelara, Tremfya, Simponi |
| Intercept Pharmaceuticals, INC. | $198.05 | 2022-2024 | Ocaliva |
| Ardelyx, INC. | $181.15 | 2023-2025 | Ibsrela |
| Gilead Sciences, INC. | $101.31 | 2025 | |
| Qol Medical, LLC | $97.97 | 2022 | |
| Amgen INC. | $94.64 | 2021-2023 | Avsola, Amjevita |
| Astrazeneca Pharmaceuticals LP | $93.07 | 2021 | |
| Nestle Healthcare Nutrition INC. | $90.28 | 2022-2023 | |
| Vifor Pharma, INC. | $82.09 | 2023-2025 | Veltassa |
| Celgene Corporation | $81.78 | 2023-2024 | Zeposia |
| Ironwood Pharmaceuticals, INC | $67.53 | 2022-2024 | Linzess |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.